The Clinical and Cost-Effectiveness of an Artificial Intelligence-Synthesized Nursing Care Bundle in Preventing Medical Device-Related Pressure Injuries
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 220
- Locations
- 1
- Primary Endpoint
- Incidence of Medical device related pressure injury
Study Overview
Brief Summary
Medical device-related pressure injuries (MDRPIs) are an important and largely preventable patient safety problem, particularly in intensive care units where the use of medical devices is frequent and prolonged. A recent meta-analysis reported an MDRPI incidence of approximately 19% among adults in critical care settings. Although evidence-based recommendations for MDRPI prevention are available, their consistent and sustainable integration into routine nursing care remains challenging. Care bundles may facilitate the translation of evidence into routine clinical practice; however, existing MDRPI prevention bundles vary considerably in their components and implementation strategies, and evidence regarding their clinical and economic effectiveness remains limited.
This study aims to develop an artificial intelligence (AI)-synthesized nursing care bundle for the prevention of MDRPIs and to evaluate its clinical effectiveness and cost-effectiveness compared with routine care. The care bundle will consist of 3-5 evidence-based components identified through a systematic review of the literature and AI-assisted evidence synthesis. The draft bundle will subsequently be evaluated and finalized through a two-round Delphi process involving experts with experience in MDRPI prevention. Before clinical implementation, participating nurses will receive standardized training, and their adherence to the care bundle will be assessed by the research team, with an adherence level of ≥95% required before implementation.
The clinical effectiveness of the finalized care bundle will be evaluated in a randomized controlled trial conducted in an adult intensive care unit. A total of 220 patients will be allocated in a 1:1 ratio, using blocked stratified randomization based on MDRPI risk level, to either the intervention group receiving the AI-synthesized nursing care bundle or the control group receiving routine care. All medical devices in place at enrollment will be recorded, and participants will be followed for up to 14 days; the primary outcome will be the occurrence of an MDRPI related to these devices during the follow-up period. An economic evaluation will be conducted from the hospital perspective based on product utilization, nursing labor time, and hospitalization-related resource use, and the cost-effectiveness of the intervention will be assessed using the incremental cost-effectiveness ratio.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Single (Outcomes Assessor)
Masking Description
Due to the nature of the intervention, nurses delivering the care bundle and the investigators cannot be blinded to group allocation. MDRPI outcomes will be assessed by a wound care nurse who is blinded to group allocation. Statistical analyses will also be performed by a statistician blinded to group allocation, with the groups coded as A and B.
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults aged 18 years or older
- •Presence of at least one medical device placed for diagnostic or therapeutic purposes.
- •No existing medical device-related pressure injury (MDRPI) at the time of study enrollment.
- •Expected length of stay in the intensive care unit of at least 24 hours.
- •Willingness to participate in the study and provision of written informed consent by the participant or their legal representative.
Exclusion Criteria
- •Presence of only a peripheral intravenous (IV) catheter as a medical device. (Peripheral IV catheters are excluded because they are routinely present in ICU patients and their replacement frequency and treatment-related use may vary rapidly and unpredictably)
- •Presence of an existing MDRPI at the time of study enrollment.
- •Expected intensive care unit stay of less than 24 hours.
- •Refusal to participate, failure to provide informed consent, or withdrawal of consent during the study.
Arms & Interventions
Routine Care
Participants allocated to this group will receive the routine care currently provided in the intensive care unit.
Intervention: Control Group (Other)
AI-Synthesized Nursing Care Bundle
Participants allocated to this group will receive the AI-synthesized nursing care bundle for the prevention of medical device-related pressure injuries (MDRPIs), in addition to the routine care provided in the intensive care unit.
Intervention: Care Bundle Group (Other)
Outcomes
Primary Outcomes
Incidence of Medical device related pressure injury
Time Frame: Up to 14 days after enrollment
Occurrence of at least one MDRPI (yes/no) related to the medical devices in place at enrollment. Skin and mucosa under and around each device will be assessed during daily visits, and MDRPIs will be documented using the Medical Device Monitoring and Pressure Injury Event Follow-up Form and staged according to the National Pressure Injury Advisory Panel (NPIAP) classification system. Incidence will be calculated as the proportion of patients developing an MDRPI among all patients with medical devices in each group.
Secondary Outcomes
- Total cost per participant(Up to 14 days after enrollment)